Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2022 | 06-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,599,726 | 2,410,200 | 3,081,875 | 2,896,485 | 2,747,472 |
| Marketable Securities | 230,018 | 182,844 | 157,344 | 90,936 | 37,083 |
| Receivables | 3,337,250 | 3,515,458 | 3,438,354 | 3,415,867 | 3,471,905 |
| Inventories | 1,214,179 | 1,269,176 | 1,333,869 | 1,353,461 | 1,431,011 |
| Other current assets | 244,671 | 239,786 | 254,671 | 218,982 | 217,837 |
| TOTAL | $7,625,844 | $7,617,464 | $8,266,113 | $7,975,731 | $7,905,307 |
| Non-Current Assets | |||||
| PPE Net | 2,019,974 | 2,157,378 | 2,356,790 | 2,426,706 | 2,454,252 |
| Investments And Advances | 736,330 | 816,346 | 917,893 | 870,633 | 906,087 |
| Intangibles | 7,248,413 | 7,500,524 | 8,323,920 | 8,426,363 | 8,321,368 |
| Other Non-Current Assets | 971,803 | 1,018,472 | 870,247 | 880,288 | 883,033 |
| TOTAL | $10,976,520 | $11,492,720 | $12,468,850 | $12,603,990 | $12,564,740 |
| Total Assets | $18,602,360 | $19,110,190 | $20,734,960 | $20,579,720 | $20,470,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,055,038 | 1,172,094 | 1,204,650 | 1,015,269 | 986,922 |
| Other current liabilities | 2,757,766 | 2,794,907 | 2,907,441 | 2,954,779 | 2,830,100 |
| TOTAL | $5,482,167 | $5,702,143 | $5,262,189 | $5,048,389 | $5,292,378 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,199,707 | 1,509,592 | 2,475,960 | 2,545,698 | 686,778 |
| TOTAL | $1,243,656 | $1,557,340 | $2,569,398 | $2,630,974 | $2,593,564 |
| Total Liabilities | $6,725,830 | $7,259,491 | $7,831,595 | $7,679,363 | $7,885,942 |
| Shareholders' Equity | |||||
| Common Shares | 741,607 | 793,108 | 906,409 | 937,309 | 937,309 |
| Retained earnings | 7,225,718 | 7,122,354 | 8,796,832 | 8,965,603 | 8,608,245 |
| Other shareholders' equity | 2,780,147 | 2,736,592 | 1,761,549 | 1,514,816 | 1,564,877 |
| TOTAL | $11,876,530 | $11,850,700 | $12,903,360 | $12,900,360 | $12,584,110 |
| Total Liabilities And Equity | $18,602,360 | $19,110,191 | $20,734,955 | $20,579,723 | $20,470,052 |